对可乐定降压作用的明显抵抗。
Apparent resistance to hypotensive effect of clonidine.
作者信息
Wing L M, Reid J L, Davies D S, Dargie H J, Dollery C T
出版信息
Br Med J. 1977 Jan 15;1(6054):136-8. doi: 10.1136/bmj.1.6054.136.
Abstract
Clonidine failed to reduce the blood pressures of two patients with essential hypertension. On was given 5-4 mg/day and the other 6 mg/day, and their respective peak plasma clonidine concentrations were 26-2 ng/ml and 14-4 ng/ml. Several months after the end of clonidine treatment a single oral dose of 0-3 mg of clonidine produced maximum falls in blood pressure of 30/22 mm Hg and 88/41 mm Hg with peak plasma clonidine concentrations of 1-4 ng/ml and 0-9 ng/ml. Resistance to the hypotensive effect of high doses of clonidine may be due to stimulation of peripheral alpha-adrenoceptors causing vasoconstriction, which maintains a raised blood pressure.
摘要
可乐定未能降低两名原发性高血压患者的血压。一名患者给予5 - 4毫克/天，另一名患者给予6毫克/天，他们各自的可乐定血浆峰值浓度分别为26 - 2纳克/毫升和14 - 4纳克/毫升。可乐定治疗结束数月后，单次口服0 - 3毫克可乐定，血压最大降幅分别为30/22毫米汞柱和88/41毫米汞柱，可乐定血浆峰值浓度分别为1 - 4纳克/毫升和0 - 9纳克/毫升。对高剂量可乐定降压作用的抵抗可能是由于外周α - 肾上腺素能受体受刺激导致血管收缩，从而维持血压升高。
相似文献
1
Apparent resistance to hypotensive effect of clonidine.
Br Med J. 1977 Jan 15;1(6054):136-8. doi: 10.1136/bmj.1.6054.136.
2
Pharmacokinetic and concentration-effect relationships of clonidine in essential hypertension.
Eur J Clin Pharmacol. 1977 Dec 28;12(6):463-9. doi: 10.1007/BF00561067.
3
A sliding intravenous dose schedule for clonidine in hypertensive patients.
Clin Pharmacol Ther. 1976 Jul;20(1):31-5. doi: 10.1002/cpt197620131.
4
Absence of tolerance to hypotensive effects of clonidine in spontaneously hypertensive rats.
Jpn J Pharmacol. 1995 Apr;67(4):407-410. doi: 10.1254/jjp.67.407.
5
Plasma clonidine levels in hypertension.
Clin Pharmacol Ther. 1983 Sep;34(3):341-6. doi: 10.1038/clpt.1983.177.
6
Plasma renin activity, blood pressure and sodium excretion during treatment with clonidine.
Acta Med Scand. 1975 Jun;197(6):457-61. doi: 10.1111/j.0954-6820.1975.tb04951.x.
7
Pharmacokinetics of clonidine and its relation to the hypotensive effect in patients.
Br J Clin Pharmacol. 1978 Sep;6(3):227-32. doi: 10.1111/j.1365-2125.1978.tb04589.x.
8
Effects of long-term administration of clonidine on plasma renin activity.
Can Med Assoc J. 1976 Dec 4;115(11):1107-8.
9
General pharmacology of the novel centrally acting antihypertensive agent moxonidine.
Arzneimittelforschung. 1988 Oct;38(10):1426-34.
10
Antihypertensive effects of a new transdermal delivery system for clonidine (M-5041T) in spontaneously hypertensive rats.
Arch Int Pharmacodyn Ther. 1994 May-Jun;327(3):294-308.
引用本文的文献
1
How should dexmedetomidine and clonidine be prescribed in the critical care setting?
Rev Bras Ter Intensiva. 2021 Oct-Dec;33(4):600-615. doi: 10.5935/0103-507X.20210087. Epub 2022 Jan 24.
2
Clinical Practice: Should we Radically Alter our Sedation of Critical Care Patients, Especially Given the COVID-19 Pandemics?
Rom J Anaesth Intensive Care. 2020 Dec;27(2):43-76. doi: 10.2478/rjaic-2020-0018. Epub 2021 Jan 4.
3
Randomized clinical trial to compare the efficacy to improve the quality of surgical field of hypotensive anesthesia with clonidine or dexmedetomidine during functional endoscopic sinus surgery.
Eur Arch Otorhinolaryngol. 2019 Nov;276(11):3095-3104. doi: 10.1007/s00405-019-05575-6. Epub 2019 Jul 30.
4
Effects of chromogranin A deficiency and excess in vivo: biphasic blood pressure and catecholamine responses.
J Hypertens. 2010 Apr;28(4):817-25. doi: 10.1097/HJH.0b013e328336ed3e.
5
The Fourth Lilly Prize Lecture, University of Aberdeen, September 1980. The clinical pharmacology of clonidine and related central antihypertensive agents.
Br J Clin Pharmacol. 1981 Sep;12(3):295-302. doi: 10.1111/j.1365-2125.1981.tb01217.x.
6
Long-term clonidine effects on autonomic function in essential hypertensive man.
Eur J Clin Pharmacol. 1981 Jan;19(1):25-32. doi: 10.1007/BF00558378.
7
Relationship between the cardiovascular effects and steady-state kinetics of clonidine in hypertension. Demonstration of a therapeutic window in man.
Eur J Clin Pharmacol. 1984;26(3):309-13. doi: 10.1007/BF00548760.
8
Relationship between plasma concentrations of clonidine and mean arterial pressure during an accidental clonidine overdose.
Br J Clin Pharmacol. 1986 Jan;21(1):71-4. doi: 10.1111/j.1365-2125.1986.tb02824.x.
9
Pharmacokinetics of clonidine and its relation to the hypotensive effect in patients.
Br J Clin Pharmacol. 1978 Sep;6(3):227-32. doi: 10.1111/j.1365-2125.1978.tb04589.x.
本文引用的文献
1
Evidence for an alpha-sympathomimetic component in the effects of catapresan on vasomotor centres: antagonism by piperoxane.
Eur J Pharmacol. 1971;14(1):98-100. doi: 10.1016/0014-2999(71)90130-0.
2
Interactions between 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155, Catapresan) and alpha-adrenergic blocking drugs.
Eur J Pharmacol. 1970 Jan;9(1):7-13. doi: 10.1016/0014-2999(70)90313-4.
3
Central and peripheral alpha adrenergic activity of imidazoline derivatives.
Life Sci. 1974 Sep 1;15(5):887-99. doi: 10.1016/0024-3205(74)90005-8.
4
Clinical pharmacology and pharmacokinetics of clonidine.
Clin Pharmacol Ther. 1976 Jan;19(1):11-7. doi: 10.1002/cpt197619111.
5
Clonidine overdose.
Br Med J. 1975 Oct 4;4(5987):23. doi: 10.1136/bmj.4.5987.23.
Zotero 插件